Stock Research for BIESF


Featured Broker: Ally Invest

Get the due diligence for another stock.


BIESF Stock Chart & Research Data

The BIESF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIESF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BIESF Due diligence Resources & Stock Charts

The BIESF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIESF Detailed Price Forecast - CNN Money CNN View BIESF Detailed Summary - Google Finance
Yahoo View BIESF Detailed Summary - Yahoo! Finance Zacks View BIESF Stock Research & Analysis -

Stock Analysis

TradeIdeas View BIESF Trends & Analysis - Trade-Ideas Barrons View BIESF Major Holders - Barrons
NASDAQ View BIESF Call Transcripts - NASDAQ Seeking View BIESF Breaking News & Analysis - Seeking Alpha
Spotlight View BIESF Annual Report - OTC Report View BIESF OTC Short Report -
TradeKing View BIESF Fundamentals - TradeKing Charts View BIESF SEC Filings - Bar Chart
WSJ View Historical Prices for BIESF - The WSJ Morningstar View Performance/Total Return for BIESF - Morningstar
MarketWatch View the Analyst Estimates for BIESF - MarketWatch CNBC View the Earnings History for BIESF - CNBC
StockMarketWatch View the BIESF Earnings - StockMarketWatch MacroAxis View BIESF Buy or Sell Recommendations - MacroAxis
Bullish View the BIESF Bullish Patterns - American Bulls Short Pains View BIESF Short Pain Metrics -

Social Media Mentions

StockTwits View BIESF Stock Mentions - StockTwits PennyStocks View BIESF Stock Mentions - PennyStockTweets
Twitter View BIESF Stock Mentions - Twitter Invest Hub View BIESF Investment Forum News - Investor Hub
Yahoo View BIESF Stock Mentions - Yahoo! Message Board Seeking Alpha View BIESF Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BIESF - Insider Cow View Insider Transactions for BIESF - Insider Cow
CNBC View BIESF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIESF - OTC Markets
Yahoo View Insider Transactions for BIESF - Yahoo! Finance NASDAQ View Institutional Holdings for BIESF - NASDAQ

Stock Charts

FinViz View BIESF Stock Insight & Charts - StockCharts View BIESF Investment Charts -
BarChart View BIESF Stock Overview & Charts - BarChart Trading View View BIESF User Generated Charts - Trading View

Latest Financial News for BIESF

ADMA: Biotest Share Retirement Good for Shareholders
Posted on Monday June 04, 2018

ADMA Biologics, Inc. (ADMA) filed its 10-K and press release for its first quarter 2018 financial results on May 14, 2018. The highlights year to date have included the release of the first commercial batch of Nabi-HB to be manufactured under its ownership, the retirement of 8.6 million shares issued to Biotest and the grant of a patent for treating respiratory infections related to RI-002. The facility has been inspection-ready by the turn of the year and we await the arrival of the FDA inspection team.

BRIEF-Shanghai RAAS Blood Products Plans Asset Acquisition, Share Trade Remains Suspended
Posted on Thursday March 22, 2018


Biotest sheds U.S. business to allay U.S. concerns of Chinese takeover
Posted on Friday January 19, 2018

Biotest (BIOG.DE) said on Friday that it has sold its U.S. operations, allaying national security concerns by U.S. authorities and paving the way for the German company's sale to a Chinese investor. The Committee on Foreign Investment in the United States (CFIUS) had initially blocked the sale of the German blood plasma products maker to the Chinese investor Creat Group Corp. The sale of U.S. operations, to an undisclosed buyer and for an undisclosed price, means that Biotest's sale to Creat would proceed.

ADMA: Third Quarter 2017 Financial Results and Corporate Update
Posted on Monday November 13, 2017

By John Vandermosten, CFA NASDAQ:ADMA ADMA Biologics, Inc. (NASDAQ: ADMA) experienced its first full quarter merged with the Biotest Therapy Business Unit (BTBU) and reported 3Q:17 results on November ...

Enter a stock symbol to view the stock details.